摘要
目的探讨乙肝患者肝组织中HBVcccDNA与血清中HBVDNA、HBeAg的关系。方法采用实时荧光定量聚合酶链反应检测乙肝患者肝组织中HBVcccDNA及血清HBVDNA,同时采用ELISA检测其血清中免疫指标HBeAg。结果30例HB-sAg、HBeAg、抗HBc阳性的乙肝患者血清中HBVDNA阳性28例阳性率93.33%,肝组织中HBVcccDNA阳性19例阳性率63.33%,两者比较差异有显著性P<0.05。30例HBsAg、抗HBe、抗HBc阳性的乙肝患者血清中HBVDNA阳性8例阳性率26.67%,肝组织中HBVcccDNA阳性5例阳性率16.67%,两者比较差异无显著性P>0.05。10例脂肪肝患者血清HBVDNA阴性,肝组织中未检出HBVcccDNA。结论(1)血清HBVDNA或HBeAg阳性并不能完全确定肝内一定存在乙肝病毒正在复制。(2)HBeAg阴性抗HBe阳性不能完全确定肝内一定没有乙肝病毒复制。(3)要确定肝内病毒是否存在复制必须通过肝组织HB-VcccDNA检测来证实。
Objective To explore the correlation between liver tissue cccDNA and serum HBV DNA, HBeAg in patients with hepatitis. Methods Hepatitis B patients liver tissue cccDNA and serum HBV DNA were defected by Real - time fluorescence quantitative polymerase chain reaction,while immune parameters of HBeAg in Serum was defeefed by ELISA. Results Of 30 cases of HBsAg, HBeAg, anti- HBc- positive hepatitis B patients, positive HBV DNA in serum was 28 cases, positive rate 93.33% ; 19 cases, positive rate 63. 33% , the difference between the two is significant ( P 〈 0.05 ). of 30 cases of HBsAg, anti - HBe, anti - HBc hepatitis B patients, positive HBVDNA in serum was eight cases with postive rate 26. 67% ; positive HBVcccDNA in liver tissne was five cases with positive rate 16.67% , the difference between the two was not significant (P 〉0.05) of 10 cases of patients with fatty liver,serum HBV DNA was negative. Conclusions ( 1 ) HBVDNA occured in serum of positive HBeAg was not necesarily to have virus replication ; (2) negative HBeAg or anti HBe was not necesqrily to deny virus replication ; (3) to determine whether the vivus is replicated or not, it showld be confirmed by detection of HBV cccDNA in liver fissue.
出处
《医学研究杂志》
2008年第3期60-61,共2页
Journal of Medical Research
基金
杭州市科技局科研项目(2004433Q03)
杭州市卫生局重点传染专科课题